NCT06651073View on ClinicalTrials.gov

ATTR-CM: A Multi-country, Non-interventional Disease Registry

RecruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 3, 2025

Study Completion Date

October 3, 2025

Conditions

Transthyretin Amyloid Cardiopathy

Interventions

OTHER

Observational

There is no intervention involved in the study. It is purely observational.

Trial Locations (1)

100225

RECRUITING

National Taiwan University, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY